GlassScriptPhysician profile
Regina Frederick
NPI 1447731302
$8,282.15
in general payments reported to CMS, 2019-2025
34 companies · $2,490 in 2025
The $2,490 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,343 · 2022: $1,613 · 2023: $1,835 · 2024: $1,000 · 2025: $2,490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,071 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,071.42 |
| Education | $253.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,362.83 | 2021-2025 | |
| Amgen INC. | $1,210.49 | 2021-2025 | Enbrel, Tavneos, Otezla |
| Janssen Biotech, INC. | $610.90 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $545.88 | 2021-2025 | |
| Glaxosmithkline, LLC. | $460.70 | 2021-2025 | Benlysta, Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $293.33 | 2021-2025 | Taltz, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $171.16 | 2021-2024 | Saphnelo, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.85 | 2021-2024 | Ofev, Cyltezo, Jardiance |
| E.R. Squibb & Sons, L.L.C. | $155.69 | 2021-2023 | Orencia |
| Ucb, INC. | $108.70 | 2022-2025 | Bimzelx |
| Otsuka America Pharmaceutical, INC. | $101.44 | 2024 | Rexulti |
| Actelion Pharmaceuticals US, INC. | $100.24 | 2021-2023 | Uptravi, Opsumit |
| Mallinckrodt Hospital Products INC. | $99.65 | 2021-2022 | |
| Novo Nordisk INC | $95.49 | 2024 | Rybelsus, Ozempic |
| Pfizer INC. | $90.70 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $88.03 | 2022-2023 | Lupkynis |
| Sobi, INC | $85.12 | 2022-2025 | |
| Horizon Therapeutics Plc | $54.94 | 2021-2023 | Krystexxa |
| Alexion Pharmaceuticals, INC. | $54.10 | 2023-2025 | Strensiq |
| Pharming Healthcare, INC. | $54.06 | 2023-2024 | Ruconest |
| Genentech USA, INC. | $45.06 | 2021-2023 | Actemra |
| Organon LLC | $42.37 | 2023-2024 | Renflexis |
| Gilead Sciences, INC. | $40.70 | 2024 | |
| Ibsa Pharma INC. | $35.64 | 2023-2024 | Tirosint, Licart, Licart |
| Bayer Healthcare Pharmaceuticals INC. | $34.26 | 2024 | |
| Depuy Synthes Sales INC. | $33.63 | 2022 | |
| Genzyme Corporation | $27.48 | 2025 | |
| Alnylam Pharmaceuticals INC. | $27.44 | 2024 | Onpattro |
| Radius Health, INC. | $17.32 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $16.91 | 2024 | |
| Janssen Pharmaceuticals, INC | $16.37 | 2024 | Xarelto |
| Octapharma USA, INC. | $14.26 | 2022 | |
| Exact Sciences Corporation | $13.97 | 2024 | Cologuard Collection Kit |
| Antares Pharma, INC. | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Frederick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.